TGFB1 and neoplasm: In addition to its well-documented effects on tumor cells, TGFβ signaling is emerging as a central mediator of the tumor microenvironment, promoting cancer-associated fibrosis and impeding the effector function of cytotoxic T-lymphocytes (16, 18).